Spots Global Cancer Trial Database for testosterone cypionate
Every month we try and update this database with for testosterone cypionate cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Bipolar Androgen-based Therapy for Prostate Cancer (BAT) | NCT01750398 | Recurrent Prost... | Testosterone cy... Goserelin Leuprolide | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Testosterone Replacement for Fatigue in Male Hypogonadic Advanced Cancer Patients | NCT00965341 | Advanced Cancer | Testosterone Placebo | 18 Years - | M.D. Anderson Cancer Center | |
| Sex-Mismatched Allogeneic Bone Marrow Transplantation for Men With Metastatic Castration-Resistant Prostate Cancer | NCT02995330 | Prostate Cancer | Bone marrow tra... Cytoxan testosterone cy... | 18 Years - 75 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Testosterone and Olaparib in Treating Patients With Castration-Resistant Prostate Cancer | NCT03516812 | Castration-Resi... Prostate Adenoc... | Laboratory Biom... Olaparib Quality-of-Life... Survey Administ... Testosterone En... Testosterone Cy... | 18 Years - | University of Washington | |
| Bipolar Androgen-based Therapy for Prostate Cancer (BAT) | NCT01750398 | Recurrent Prost... | Testosterone cy... Goserelin Leuprolide | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Biomarker Analysis of Castration-resistant Prostate Cancer Undergoing Bipolar Androgen Therapy | NCT04424654 | Prostate Cancer | Testosterone cy... | 18 Years - | Hospital Sirio-Libanes | |
| Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression | NCT04363164 | Castration Resi... | Testosterone cy... Enzalutamide Testosterone en... | 18 Years - 90 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| RE-sensitizing With Supraphysiologic Testosterone to Overcome REsistance (The RESTORE Study) | NCT02090114 | Prostate Cancer | Testosterone cy... Testosterone En... Abiraterone ace... Enzalutamide | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Sex-Mismatched Allogeneic Bone Marrow Transplantation for Men With Metastatic Castration-Resistant Prostate Cancer | NCT02995330 | Prostate Cancer | Bone marrow tra... Cytoxan testosterone cy... | 18 Years - 75 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Perioperative Testosterone Replacement Therapy for the Improvement of Post-Operative Outcomes in Patients With Low Testosterone | NCT04731376 | Hypogonadism Malignant Urina... Urinary System ... Urinary System ... | Best Practice Quality-of-Life... Questionnaire A... Testosterone Cy... | 18 Years - | Emory University | |
| Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for Patients With Metastatic Castration Resistant Prostate Cancer | NCT06305598 | Castration-Resi... Metastatic Pros... Stage IVB Prost... | Biopsy Bone Scan Computed Tomogr... Leuprolide Acet... Magnetic Resona... Survey Administ... Testosterone Cy... | 18 Years - | Roswell Park Cancer Institute | |
| Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer | NCT06059118 | Prostate Cancer | DFMO testosterone cy... Luteinizing hor... Enzalutamide | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPC | NCT06100705 | Metastatic Cast... | Testosterone Cy... Sipuleucel-T | 18 Years - | Yale University | |
| Testosterone Replacement for Fatigue in Male Hypogonadic Advanced Cancer Patients | NCT00965341 | Advanced Cancer | Testosterone Placebo | 18 Years - | M.D. Anderson Cancer Center | |
| Extreme Bipolar Androgen Therapy With Darolutamide and Testosterone Cypionate in Patients With Metastatic Castration-Resistant Prostate Cancer (ExBAT Trial) | NCT04558866 | Prostate Cancer | Testosterone Cy... Darolutamide | 18 Years - | Latin American Cooperative Oncology Group | |
| RE-sensitizing With Supraphysiologic Testosterone to Overcome REsistance (The RESTORE Study) | NCT02090114 | Prostate Cancer | Testosterone cy... Testosterone En... Abiraterone ace... Enzalutamide | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Supraphysiological Androgen to Enhance Chemotherapy Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study | NCT06039371 | Castration-Resi... Metastatic Pros... Stage IVB Prost... | Biopsy Biospecimen Col... Bone Scan Carboplatin Computed Tomogr... Etoposide Quality-of-Life... Questionnaire A... Testosterone Cy... | 18 Years - | University of Washington |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
